Canada at a glance
- Population
- 41.7 million 2025
- Life expectancy at birth
- 82.1 years, 2024
- People aged 65 and over
- 20.3 % of people, 2025
- Health spending per person
- 6,378 US$ per person, 2024
- Doctors
- 2.82 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Canada Antiemetic Drugs Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$197.1 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $507.6 Mn | — | — |
| 2025 (base) | $525.9 Mn | +$18.3 Mn | — |
| 2026 (forecast) | $544.8 Mn | +$18.9 Mn | +3.6% |
| 2027 (forecast) | $564.5 Mn | +$19.6 Mn | +7.3% |
| 2028 (forecast) | $584.8 Mn | +$20.3 Mn | +11.2% |
| 2029 (forecast) | $605.8 Mn | +$21.1 Mn | +15.2% |
| 2030 (forecast) | $627.6 Mn | +$21.8 Mn | +19.3% |
| 2031 (forecast) | $650.2 Mn | +$22.6 Mn | +23.6% |
| 2032 (forecast) | $673.6 Mn | +$23.4 Mn | +28.1% |
| 2033 (forecast) | $697.9 Mn | +$24.3 Mn | +32.7% |
| 2034 (forecast) | $723.0 Mn | +$25.1 Mn | +37.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $525.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $723.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 3.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Drug class, indication and end user (see all) |
| Key players | Merck & Co., Inc., Helsinn, Heron Therapeutics, Novartis AG, Eisai Co. (see all) |
| Regulator in Canada | Health CanadaSource: Health Canada. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Antiemetic drugs prevent nausea and vomiting from chemotherapy, surgery, pregnancy and motion sickness.
Key segments of the antiemetic Drugs market include drug class (5-HT3 Antagonists, NK1 Antagonists and Dopamine Antagonists) and indication (Chemotherapy-Induced, Post-Operative and Pregnancy).
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the antiemetic Drugs market.
Ready-to-use formulations, biosimilars and supply security programmes give the antiemetic Drugs market room to grow.
Drug shortages, price controls, generic competition and strict hospital budgets hold back the antiemetic Drugs market.
The antiemetic Drugs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Health Canada reviews drugs and must authorise them before they can be sold.[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.[2]
[1] Health Canada. Checked 14 Nov 2026.
[2] Health Canada. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for antiemetic Drugs. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Canada.
What doctors and scientists are doing in Antiemetic Drugs right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
From our blog
Canada · 1 shared keyword
Canada · 1 shared keyword
Canada · 1 shared keyword
Canada · 1 shared keyword
Canada · 1 shared keyword
Canada · 1 shared keyword
Digital Health · Canada
Digital Health · Canada
Medical Devices · Canada
Medical Devices · Canada
Digital Health · Canada
Healthcare Services · Canada